supply of coronary drug eluting stentscoronary drug eluting stents, ( sr ph code 153047 ) coronary drug eluting stents with ( 1 ) cobalt chromium alloy ( 2 ) coating of bioabsorbable polymer carrier with abluminal and gradient coating for active drug shown to be effective in preventing neo-intimal hyperplasia ) ( 3 ) stent diameter should be from 2.5mm to 4mm . the length of the stent should be from 12mm to 38 mm. ( 4 ) the strut thickness should be 91 micron or less. ( 5 ) stent delivery system should be monorail ( single operator exchange or rapid exchange ) . ( 6 ) stent should be compatible with 5fr guiding catheter ( 7 ) stent design should be open cell type. ( 8 ) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. ( 9 ) the long term efficacy and safety of the stent, the rates of in-stent restenosis ( isr ) and in-situ thrombosis ( ist ) should be documented / published in peer reviewed scientific journals. ( 10 ) safety of abbreviated ( one month ) dual antiplatelet therapy for high bleeding risk patients should be documented in peer reviewed journals. ( 11 ) the manufacturer / supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. ( reference:bis catalogue ) . unit: no [ warranty period: 18 months after the date of delivery ]